COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 1223: Articles 12221-12230  | Next

Safety and Immunogenicity of the COVID-19 Vaccine BNT162b2 in Patients Undergoing Chemotherapy for Solid Cancer
Funakoshi, Y., Yakushijin, K., Ohji, G., Hojo, W., Sakai, H., Takai, R., Nose, T., Ohata, S., Nagatani, Y., Koyama, T., Kitao, A., Nishimura, M., Imamura, Y., Kiyota, N., Harada, K., Tanaka, Y., Mori, Y., Minami, H.
10.1101/2021.10.25.21265324 — Posted: 2021-10-25
Main COVID-19 information sources in a culturally and linguistically diverse community in Sydney, Australia: A cross-sectional survey
Ayre, J., Muscat, D. M., Mac, O., Batcup, C., Cvejic, E., Pickles, K., Dolan, H., Bonner, C., Mouwad, D., Zachariah, D., Turalic, U., Santalucia, Y., Chen, T., Vasic, G., McCaffery, K. J.
10.1101/2021.10.24.21265451 — Posted: 2021-10-25
Seroconversion rate and socioeconomic and ethnic risk factors for SARS-CoV-2 infection in children in a population-based cohort
Brinkmann, F., Diebner, H. H., Matenar, C., Schlegtendal, A., Eitner, L., Timmesfeld, N., Maier, C., Luecke, T.
10.1101/2021.10.21.21265322 — Posted: 2021-10-25
A randomized, controlled, feasibility study of RD-X19 in patients with mild-to-moderate COVID-19 in the outpatient setting
Stasko, N., Cockrell, A. S., Kocher, J. F., Henson, I., Emerson, D., Wang, Y., Smith, J. R., Henderson, N. H., Wood, H., Bradrick, S. S., Jones, T., Santander, J., McNeil, J. G.
10.1101/2021.10.17.21265058 — Posted: 2021-10-25
Psychological Distress Before and During the COVID-19 Pandemic: Sociodemographic Inequalities in 11 UK Longitudinal Studies
Patel, K., Robertson, E., Kwong, A. S. F., Griffith, G. J., Willan, K., Green, M. J., Di Gessa, G., Huggins, C., McElroy, E., Thompson, E. J., Maddock, J., Niedzwiedz, C. L., Henderson, M., Richards, M., Steptoe, A., Ploubidis, G. B., Moltrecht, B., Booth, C., Fitzsimons, E., Silverwood, R., Patalay, P., Porteous, D., Katikireddi, S. V.
10.1101/2021.10.22.21265368 — Posted: 2021-10-25
Aligning staffing schedules with testing and isolation strategies reduces the risk of COVID-19 outbreaks in carceral and other congregate settings: A simulation study
Hoover, C. M., Skaff, N. K., Blumberg, S., Fukunaga, R.
10.1101/2021.10.22.21265396 — Posted: 2021-10-25
Effects of Confounding Bias in COVID-19 and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors
Doll, M. K. K., Pettigrew, S. M., Ma, J., Verma, A.
10.1101/2021.10.22.21265390 — Posted: 2021-10-25
The Impact of SARS-CoV-2 Lineages (Variants) on the COVID-19 Epidemic in South Africa
Mabuka, T., Naidoo, N., Ncube, N., Yiga, T., Ross, M., Kurehwa, K., Nare, M., Silaji, A., Ndemera, T., Lemeke, T., Ademola, T. R., Macharia, W., Sithole, M.
10.1101/2021.10.22.21265316 — Posted: 2021-10-25
SARS-CoV-2 Receptor Binding Domain IgG Response to AstraZeneca (AZD1222) COVID-19 Vaccination, Jamaica
Leys, Y. E., Nwokocha, M., Walker, J. P., Butterfield, T. R., Frater, V., Thompson, T. K., Anderson, M., Cloherty, G. A., Anzinger, J. J.
10.1101/2021.10.22.21265401 — Posted: 2021-10-25
Safety and Effectiveness of COVID-19 SPUTNIK V Vaccine in Dialysis Patients
Rosa-Diez, G., Papaginovic-Leiva, M. M., Lombi, F., Crucelegui, M. S., Martinez, R. D., Trimarchi, H., Schiavelli, R., Grizzo, M., Rano, M., . Heguilen, R. M., Jones, R. A., Gonzalez-Paganti, L., Ferrari, M., Zingoni, P., Kjohede, V., Geffner|, J. R., Ferrante, D., Gonzalez Bernaldo de Quiros, F., Pagotto, V.
10.1101/2021.10.21.21265349 — Posted: 2021-10-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).